Concepts (56)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lasers, Dye | 1 | 2025 | 2 | 0.970 |
Why?
|
| Skin Diseases, Vascular | 1 | 2025 | 2 | 0.970 |
Why?
|
| Telangiectasis | 1 | 2025 | 10 | 0.960 |
Why?
|
| Low-Level Light Therapy | 1 | 2025 | 19 | 0.940 |
Why?
|
| Mohs Surgery | 1 | 2023 | 38 | 0.810 |
Why?
|
| Psoriasis | 3 | 2017 | 48 | 0.770 |
Why?
|
| Oryza | 1 | 2022 | 29 | 0.760 |
Why?
|
| Dermatitis, Atopic | 1 | 2022 | 46 | 0.740 |
Why?
|
| Skin Neoplasms | 2 | 2024 | 907 | 0.620 |
Why?
|
| Communicable Diseases, Emerging | 2 | 2016 | 67 | 0.600 |
Why?
|
| Interleukin-23 | 1 | 2017 | 15 | 0.540 |
Why?
|
| Skin Diseases, Viral | 1 | 2016 | 4 | 0.520 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2016 | 23 | 0.500 |
Why?
|
| Travel | 1 | 2016 | 125 | 0.470 |
Why?
|
| Antibodies, Monoclonal | 2 | 2017 | 1066 | 0.430 |
Why?
|
| Dermatology | 2 | 2022 | 31 | 0.390 |
Why?
|
| Global Health | 2 | 2016 | 623 | 0.380 |
Why?
|
| Dermatologic Agents | 2 | 2017 | 30 | 0.260 |
Why?
|
| Antibodies, Monoclonal, Humanized | 3 | 2017 | 556 | 0.210 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2023 | 128 | 0.190 |
Why?
|
| Internship and Residency | 2 | 2022 | 1255 | 0.190 |
Why?
|
| Skin | 2 | 2022 | 545 | 0.180 |
Why?
|
| Plant Extracts | 1 | 2022 | 138 | 0.170 |
Why?
|
| Antiviral Agents | 2 | 2016 | 824 | 0.170 |
Why?
|
| Interleukin-17 | 2 | 2017 | 130 | 0.150 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2024 | 906 | 0.140 |
Why?
|
| Receptors, Interleukin-17 | 1 | 2017 | 7 | 0.130 |
Why?
|
| Porphyria Cutanea Tarda | 1 | 2016 | 6 | 0.130 |
Why?
|
| Melanoma | 1 | 2024 | 969 | 0.130 |
Why?
|
| Skin Diseases, Parasitic | 1 | 2016 | 5 | 0.130 |
Why?
|
| Dermatomycoses | 1 | 2016 | 18 | 0.130 |
Why?
|
| Humans | 12 | 2025 | 134143 | 0.130 |
Why?
|
| Climate Change | 1 | 2016 | 62 | 0.120 |
Why?
|
| Clinical Trials as Topic | 2 | 2017 | 1161 | 0.120 |
Why?
|
| Hepatitis C | 1 | 2016 | 389 | 0.100 |
Why?
|
| Risk Assessment | 2 | 2016 | 3752 | 0.080 |
Why?
|
| Prevalence | 1 | 2016 | 2683 | 0.080 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 3119 | 0.070 |
Why?
|
| Female | 4 | 2025 | 72002 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 2587 | 0.050 |
Why?
|
| Adult | 1 | 2025 | 31943 | 0.050 |
Why?
|
| California | 1 | 2024 | 144 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2016 | 13098 | 0.050 |
Why?
|
| Patient Care | 1 | 2022 | 101 | 0.050 |
Why?
|
| Male | 4 | 2024 | 66171 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2022 | 779 | 0.040 |
Why?
|
| Curriculum | 1 | 2022 | 764 | 0.030 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2016 | 48 | 0.030 |
Why?
|
| Helminthiasis | 1 | 2016 | 78 | 0.030 |
Why?
|
| Biopsy | 1 | 2016 | 1301 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2022 | 4006 | 0.020 |
Why?
|
| Incidence | 1 | 2016 | 3421 | 0.020 |
Why?
|
| Adolescent | 1 | 2024 | 20643 | 0.020 |
Why?
|
| Child | 1 | 2024 | 25911 | 0.010 |
Why?
|
| Middle Aged | 1 | 2016 | 29395 | 0.010 |
Why?
|
| Animals | 1 | 2016 | 36518 | 0.010 |
Why?
|